Strength-based treatment approach for ADHD

  • Research type

    Research Study

  • Full title

    Could a strength- based approach to treatment improve self-management in adults with Attention Deficit Hyperactivity Disorder?

  • IRAS ID

    291103

  • Contact name

    Rebecca Champ

  • Contact email

    rebecca.champ@hud.ac.uk

  • Sponsor organisation

    University of Huddersfield

  • Clinicaltrials.gov Identifier

    NCT04832737

  • Duration of Study in the UK

    1 years, 8 months, 12 days

  • Research summary

    The aim of the research is to develop a treatment program with positive self-awareness and self-determination outcomes for adults with Attention Deficit Hyperactivity Disorder (ADHD). Current treatments are based in a characterisation of ADHD oriented on deficits impairing everyday functioning, with primary goals of symptom control and reduction. However, treatment approaches are not standardised and only evidence short-term effectiveness. This project proposes an alternative approach to understanding ADHD behaviours, supported by Self Determination Theory (SDT). Research shows SDT based treatment approaches can support engagement of intrinsic motivation and long-term integration of behavioural change. ADHD research shows individuals are impaired in some contexts but not in others and can manage well, indicating potential for ADHD neurodiverse "strengths" which could be developed and supported. Recent psychology research recommends cultivating positive psychological factors and emotions to improve mental health and wellbeing. Adults aged 18+ with a confirmed ADHD diagnosis will be invited to participate in two projects: Intensive online interviews of 1 hour will be conducted to identify, explore, and construct a theory about the factors, or "natural strengths" in lived experience of ADHD that help individuals to overcome everyday impairments. These factors will be incorporated into a pilot feasibility study of an SDT based 12-week treatment programme focusing on understanding the lived experience of ADHD and building on these strengths. The treatment will be designed for individual participants and delivered online. This study will have two sets of participants: one group will go directly to treatment, the other will go on a 12-week waiting list to create a comparison group. The second group will then be offered the 12-week treatment. Measures of experience of the participants will be looking for the feasibility, acceptability and efficacy of this treatment, as well as indicators of symptom improvement, and changes in self-awareness and self-regulation skills.

  • REC name

    South Central - Oxford C Research Ethics Committee

  • REC reference

    21/SC/0143

  • Date of REC Opinion

    13 May 2021

  • REC opinion

    Favourable Opinion